Bluelinea Société Anonyme (ALBLU.PA)

EUR 0.85

(2.41%)

Gross Profit Summary of Bluelinea Société Anonyme

Bluelinea Société Anonyme's latest annual gross profit in 2023 was -3.84 Million EUR , down -1254.27% from previous year.
Bluelinea Société Anonyme's latest quarterly gross profit in 2024 Q2 was -994.69 Thousand EUR , down 0.0% from previous quarter.
Bluelinea Société Anonyme reported a annual gross profit of -724.1 Thousand EUR in annual gross profit 2022, up 76.14% from previous year.
Bluelinea Société Anonyme reported a annual gross profit of -3.03 Million EUR in annual gross profit 2021, down -2.7% from previous year.
Bluelinea Société Anonyme reported a quarterly gross profit of 4.87 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Bluelinea Société Anonyme reported a quarterly gross profit of 9826.00 EUR for 2023 FY, up 101.36% from previous quarter.

Annual Gross Profit Chart of Bluelinea Société Anonyme (2023 - 2011)

Historical Annual Gross Profit of Bluelinea Société Anonyme (2023 - 2011)

Year	Gross Profit	Gross Profit Growth
2023	-3.84 Million EUR	-1254.27%
2022	-724.1 Thousand EUR	76.14%
2021	-3.03 Million EUR	-2.7%
2020	-2.95 Million EUR	1.85%
2019	-3.01 Million EUR	-13.67%
2018	-2.64 Million EUR	-87055.78%
2017	3045.35 EUR	43.17%
2016	2127.05 EUR	-40.55%
2015	3577.84 EUR	-99.91%
2014	3.79 Million EUR	280.03%
2013	999.2 Thousand EUR	21.73%
2012	820.81 Thousand EUR	7941.68%
2011	10.2 Thousand EUR	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	-994.69 Thousand EUR	0.0%
2023 Q2	4.87 Million EUR	0.0%
2023 FY	9826.00 EUR	101.36%
2023 Q4	4.95 Million EUR	0.0%
2022 Q4	-428.06 Thousand EUR	0.0%
2022 FY	-724.1 Thousand EUR	76.14%
2022 Q2	-296.04 Thousand EUR	0.0%
2021 FY	-3.03 Million EUR	-2.7%
2021 Q4	-1.32 Million EUR	0.0%
2021 Q2	-1.7 Million EUR	0.0%
2020 Q2	-1.44 Million EUR	0.0%
2020 FY	-2.95 Million EUR	1.85%
2020 Q4	-1.51 Million EUR	0.0%
2019 Q4	1301.65 EUR	0.0%
2019 Q2	1568.81 EUR	0.0%
2019 FY	-3.01 Million EUR	-13.67%
2018 Q2	15 Thousand EUR	0.0%
2018 Q4	3.21 Million EUR	0.0%
2018 FY	-2.64 Million EUR	-87055.78%
2017 Q4	1739.84 EUR	0.0%
2017 FY	3045.35 EUR	43.17%
2017 Q2	1305.51 EUR	0.0%
2016 FY	2127.05 EUR	-40.55%
2016 Q2	1442.92 EUR	0.0%
2016 Q4	684.13 EUR	0.0%
2015 FY	3577.84 EUR	-99.91%
2015 Q2	1121.61 EUR	0.0%
2015 Q4	2456.23 EUR	0.0%
2014 Q1	477.62 Thousand EUR	0.0%
2014 Q2	634.59 EUR	-99.87%
2014 Q4	957.95 EUR	-99.8%
2014 FY	3.79 Million EUR	280.03%
2014 Q3	477.62 Thousand EUR	75165.64%
2013 Q3	249.8 Thousand EUR	0.0%
2013 Q1	249.8 Thousand EUR	0.0%
2013 Q4	477.62 Thousand EUR	91.2%
2013 FY	999.2 Thousand EUR	21.73%
2013 Q2	249.8 Thousand EUR	0.0%
2012 FY	820.81 Thousand EUR	7941.68%
2012 Q2	205.2 Thousand EUR	0.0%
2012 Q4	249.8 Thousand EUR	21.73%
2012 Q1	205.2 Thousand EUR	0.0%
2012 Q3	205.2 Thousand EUR	0.0%
2011 Q2	2551.00 EUR	0.0%
2011 FY	10.2 Thousand EUR	0.0%
2011 Q3	2551.00 EUR	0.0%
2011 Q1	2551.00 EUR	0.0%
2011 Q4	205.2 Thousand EUR	7944.02%
2010 Q4	2551.00 EUR	0.0%

Peer Gross Profit Comparison of Bluelinea Société Anonyme

Name	Gross Profit	Gross Profit Difference
Affluent Medical SA	-1.2 Million EUR	-220.632%
Carmat SA	-30.97 Million EUR	87.577%
Diagnostic Medical Systems S.A.	15.84 Million EUR	124.286%
Euromedis Groupe	3.57 Million EUR	207.728%
Eurobio Scientific Société anonyme	53.96 Million EUR	107.13%
Ikonisys S.A.	255.82 Thousand EUR	1603.979%
Implanet S.A.	3.13 Million EUR	222.848%
Median Technologies SA	-2.55 Million EUR	-50.827%
SpineGuard SA	3.37 Million EUR	213.866%
Theraclion SA	-1.08 Million EUR	-256.131%
Euroapi S.A.	164.6 Million EUR	102.338%
Guerbet SA	197.14 Million EUR	101.952%
Ion Beam Applications SA	134.44 Million EUR	102.862%
Koninklijke Philips N.V.	7.44 Billion EUR	100.052%
Sequana Medical NV	548.04 Thousand EUR	802.051%